PRTA Q4 2018 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$194,000-15.3% YoY

Gross Profit

-$16M-8410.3% margin

Operating Income

-$23M-11729.4% margin

Net Income

-$22M-11577.8% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

-23.9%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$23M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$499M

Total Liabilities

$176M

Stockholders' Equity

$323M

Cash & Equivalents

$428M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$194,000	$229,000	-15.3%
Gross Profit	-$16M	-$33M	+51.0%
Operating Income	-$23M	-$47M	+51.9%
Net Income	-$22M	-$48M	+53.0%